Send feedback

DNAH3 p.Phe1693Leu

c.5077T>C · rs201066816 · VCV3083922

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.7364 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0404%, nfe)
Missense predictors
1/2 damaging
AlphaMissense, REVEL

Computational evidence

Protein change
AlphaMissense0.7364likely pathogenic
REVEL0.119moderately benign-leaning
⇒ AlphaMissense calls this damaging; REVEL does not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 9.1GERP 2.7, phastCons 1
Overall
CADD23.1PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM F1739L vs ClinVar F1693L) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0404% European (non-Finnish) · 477/1,179,998 alleles
Filtering AF 0.0374% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0362%
Overall 0.0335% 540/1,613,884 alleles · ultra-rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0625% 1,600
European (non-Finnish)grpmax 0.0404% 2,474
Remaining individualsnot grpmax-eligible 0.0224% 4,463
African / African-American 0.00534% 18,711
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,602
South Asian 0.00329% 30,360
Admixed American 0.00167% 59,984

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DNAH3
Protein
p.Phe1693Leu
Coding
c.5077T>C
MANE Select
NM_001347886
dbSNP
rs201066816
Type
single nucleotide variant
Location
chr16:21031269 (GRCh38)
Gene constraint
LOEUF 0.834 · pLI <0.01 (gnomAD)
Residue 1693
a UniProt-annotated variant site (found in a male with oligoasthenoteratozoospermia; uncertain significance; severely impaired sperm motility; multiple morphological abnormalities of the sperm flagella; partial loss and disintegration of the flagellar axoneme, accompanied by damage to the mitochondrial sheath); the 'aaa 2' region
Full DNAH3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dnah3-p-phe1693leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown